Articles On Cann Group (ASX:CAN)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX adds just 14.5 points in subdued day of trade Broad rally in commodity prices lifts resource stocks Crude oil bounces 1.3% as Ukraine continues to strike Russian oil infrastructure   ASX grinds higher on commodity strength A fresh att...

Two dozen esteemed sector figures recently gathered over lunch to recount their career highs and lows One luminary recalls an uncomfortable close encounter with a drug cartel, while others overcame the impact of academic and corporate frau...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Investors are stumping up cash for life sciences capital raisings – but the stories need to be well presented After an “incredibly tumultuous” nine months, fundraisings are on track to meet last year’s bumper tally of $2.9 billion Two medt...

The latest quarterlies show that key drug and diagnostics developers are well funded for the task Cann Group enters company-saving debt and equity restructuring deal A rebirth for Monash IVF?      Today’s crop of quarterly reports shows t...

ASX bounces off lows of -0.5pc to add two points Energy, defensive sectors and resources fuel gains Gold back in favour, even as prices remain subdued   Resources stocks fuel recovery The ASX was cruising for a bruising today, down 0.5%...

Highlights Discover the best workplaces for career growth in Australia. Learn about key skills and job functions in demand. Explore opportunities across multiple industries. Explore the 25 best workplaces in Australia for career g...

Highlights Discover the best workplaces for career growth in Australia. Learn about key skills and job functions in demand. Explore opportunities across multiple industries. Explore the 25 best workplaces in Australia for career g...

A Victorian man has been sentenced to 11 months imprisonment and ordered to pay a penalty of more than $225,000 after pleading guilty to insider trading charges involving a $20 million capital raise by medicinal cannabis company Cann Group...

Highlights US CBD comments influence global cannabis sentiment ASX cannabis companies may benefit from regulatory shifts Australian medicinal cannabis landscape gains attention Explore how recent US CBD developments impact ASX-lis...

ASX up 75 points to 8862.8 with 9 sectors higher Healthcare, banks and gold stocks drive gains Energy, info tech languish in the red   ASX pushes higher alongside spot gold The ASX 200 hummed higher throughout the day, closing out up 0.86...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX tips up just 0.1pc with eight sectors lower Energy, resources lead gains, outweighing losses Drop in gold price overnight undercuts gold index Copper comes out on top Move over gold, it’s copper’s turn to shine. With gold futures mov...

NZ drug maker’s expansion plans are no Aft-erthought Cann Group returns to profits – in August at least Veteran Sonic Healthcare chief calls it a day   Kiwi drug maker and distributor AFT Pharmaceuticals (ASX:AFP) is on track to achieve...

Ramsay says its full-year earnings met investors’ expectations – and if anything, were a tad higher Pacific Edge wins higher US reimbursement – but there’s a catch Leading up to AGMs, biotechs do the boardroom blitz   The ASX’s corporate...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

ASX rebounds to set new intraday high, up 0.53pc Origin Energy leads gains alongside utilities sector Unemployment rate falls, lowering interest rate cut chances   ASX sets new intraday high The ASX rebounded powerfully from yesterday’s p...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

ASX ends day on new record high at 8597 points 10 of 11 sectors higher with broad strength across market Materials leads gains, up 1.38pc   ASX almost breaks through 8600-point ceiling The ASX 200 had one of its best trading days in month...

Doctor visits dipped in April, reversing a recovery trend Mayne Pharma threatens to go legal in takeover dispute … but peace erupts at Cann Group with settlement of legal spat   We’re either a healthy lot, rely on Dr Google or simply can’...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

Highlights Surge in prescriptions for medical cannabis is accelerating domestic production and diversification Regulatory advancements enabling broader patient access and product innovation Australia emerging as a regional h...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Australia’s S&P/ASX 200 rallies 3.62% in April, showing resilience to global geopolitical and economic uncertainty Ten out of 11 sectors post gains in April, led by communications up 6.47% followed by a 6.37% comeback from tech DY6 Met...

ASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215 per ounce Oil falls to levels not seen since April 2020, at height of Covid-19 pandemic Despite pulling back on Tuesday, gold prices have h...

Highlights: ASX lifts sharply with all sectors closing higher, rebounding from prior session declines Nikkei records strong movement as markets respond to tariff rhetoric Resource and tech firms lead gains, while a few small...

ASX rallies 2.27% after shedding 4% yesterday Nikkei225 soars almost 6%, recovering from Monday’s losses Trade war threatens to escalate as China calls tariff escalations ‘a mistake’.   The ASX posted a strong gain to rise 2.27% today, re...

Companies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell Potter says Trajan shares are worth double their current price Plucky Biotron lives another day after passing the hat   On the evening of D...

Trump’s tariffs shake markets, billions wiped off ASX Gold shines as trade war fears spark safe haven rush China, EU prep retaliation as global recession fears rise   Trump’s tariffs have hit markets hard, wiping almost $30 billion off th...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

The initial buzz surrounding ASX cannabis stocks saw a lot of early investors reap a lot of early profits, while many latecomers lost their shirts. The party started when Canada and the United States moved to legalise not just medicinal can...

A few years ago the market was abuzz with excitement over ASX cannabis shares or pot stocks. Since then, the effects have worn off and this side of the market has been getting very little attention. That was until today when two ASX cannabi...

When we were kids eyeing an unobtainable treat or the not-so-imminent arrival of Santa, Mum used to tell us to be patient. Patience, indeed, is a virtue and an admirably quality to exhibit throughout one’s adult life. But there are circumst...

Nerve-repair company Renerve is set to make its ASX debut today Renerve is developing products for repair and replacement of damaged peripheral nerves It becomes only the second nerve-repair company on the ASX, after Orthocell   When Rene...

ASX slipped after early gains, then finished strongly  Energy sector helped offset losses; Quickstep, Sigma Healthcare turned heads Wall Street rallied to record highs after Trump’s win   The ASX swung from gains, to losses at lunchtime,...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K...

EBOS Group affirms current-year earnings expectations Cannabis stocks report mixed quarterly revenue and earnings trends Atomo Diagnostics gets federal backing for syphilis home test   As the competition regulator mulls the proposed $8.8...

  ASX closes  higher with consumer and utilities leading the charge Wall Street rally boosts sentiment as Nvidia jumps 4pc China’s CSI 300 index falls 5pc amid doubts over stimulus plans   The ASX closed 0.13% higher on Wednesday, thanks...

Orthocell wins Singaporean approval for its Remplir nerve-repair product Lumos wraps up $10 million whip-round amid surge of raisings in the sector ‘Nice tidy’ Cyclopharm eyes profitability from next year as US revenues grow   It’s not th...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Renewed optimism lifted the S&P/ASX 200 by 3% in September, closing at a record 8,239.20 points S&P Dow Jones Indices said small cap companies outperformed in September, with the materials sector rebounding 13%  Mithril Silver and...

ASX dips as miners lead selloff as Chinese markets close for holidays Sigma Healthcare soars 22pc after merger update Qantas tumbles 4pc as Qatar eyes Virgin Australia stake   The ASX dipped  from its record high as miners led the sellof...

ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb on fresh China stimulus Odessa soars on news of a $1,1m placement to secure exploration at its Lyndon uranium project   The ASX scal...

  ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading halt lifted   The ASX rose modestly by 0.1% on Friday, buoyed by a surge in min...